Российский кардиологический журнал (Dec 2020)
Resolution of the online meeting of Russian experts on the EMPEROR-REDUCED trial
- G. P. Arutyunov,
- A. G. Arutyunov,
- E. I. Tarlovskaya,
- A. S. Ametov,
- N. G. Vinogradova,
- A. A. Garganeeva,
- M. G. Glezer,
- I. V. Zhirov,
- M. V. Ilyin,
- N. A. Koziolova,
- A. O. Konradi,
- A. Yu. Lebedeva,
- Yu. M. Lopatin,
- S. V. Nedogoda,
- V. V. Salukhov,
- M. Yu. Sitnikova,
- S. N. Tereshchenko,
- S. N. Tolstov,
- Yu. Sh. Khalimov,
- N. R. Khasanov,
- A. I. Chesnikova,
- V. Giga,
- M. Paсker
Affiliations
- G. P. Arutyunov
- Eurasian Association of Therapists; Pirogov Russian National Research Medical University
- A. G. Arutyunov
- Eurasian Association of Therapists; Pirogov Russian National Research Medical University
- E. I. Tarlovskaya
- Eurasian Association of Therapists; Privolzhsky Research Medical University
- A. S. Ametov
- Russian Medical Academy of Continuous Professional Education
- N. G. Vinogradova
- Privolzhsky Research Medical University
- A. A. Garganeeva
- Tomsk National Research Medical Center
- M. G. Glezer
- I.M. Sechenov First Moscow State Medical University
- I. V. Zhirov
- National Medical Research Center for Cardiology
- M. V. Ilyin
- Yaroslavl State Medical University
- N. A. Koziolova
- Perm State Medical University
- A. O. Konradi
- V.A. Almazov National research medical center of Russian Ministry of Healthcare
- A. Yu. Lebedeva
- Pirogov Russian National Research Medical University
- Yu. M. Lopatin
- Volgograd State Medical University
- S. V. Nedogoda
- Volgograd State Medical University
- V. V. Salukhov
- S.M. Kirov Military Medical Academy
- M. Yu. Sitnikova
- V.A. Almazov National research medical center of Russian Ministry of Healthcare; Pavlov First State Medical University
- S. N. Tereshchenko
- National Medical Research Center for Cardiology
- S. N. Tolstov
- V.I. Razumovsky Saratov State Medical University Russian Ministry of Healthcare
- Yu. Sh. Khalimov
- S.M. Kirov Military Medical Academy
- N. R. Khasanov
- Kazan State Medical University
- A. I. Chesnikova
- Rostov State Medical University
- V. Giga
- University of Belgrade
- M. Paсker
- Baylor University
- DOI
- https://doi.org/10.15829/29/1560-4071-2020-4167
- Journal volume & issue
-
Vol. 25,
no. 11
Abstract
At the online meeting held on September 3, 2020, the results of the international multicenter trial EMPEROR-REDUCED were considered. Number of proposals and recommendations for the further study of cardiovascular and renal effects of empagliflozin and its practical use in heart failure patients were agreed.
Keywords
